[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368631-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368631-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","lights-and-shadows-of-microsatellite-status-characterization-in-gastrointestinal-cancers-in-the-era-of-cancer-precision-therapy","Lights and shadows of microsatellite status characterization in gastrointestinal cancers in the era of cancer precision therapy","","The introduction of immunotherapy has transformed solid tumor treatment by enabling novel therapeutic opportunities, including for gastrointestinal tumors lacking established options in advanced or metastatic disease. Deficient mismatch repair (dMMR) and microsatellite instability (MSI) have evolved from a colorectal-focused predictive biomarker to a key agnostic marker for stratifying patient response to immune checkpoint inhibitors. Accurate MSI/dMMR evaluation is therefore central to diagnostic-therapeutic decision-making for most gastrointestinal cancer patients, requiring reliable pathology reporting. This review summarizes routine diagnostic methods for MSI/dMMR assessment, their limitations, and diagnostic pitfalls, and discusses MSI/dMMR roles as prognostic and predictive biomarkers across non-colorectal malignancies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/lights-and-shadows-of-microsatellite-status-characterization-in-gastrointestinal-cancers-in-the-era-of-cancer-precision-therapy/368631/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/lights-and-shadows-of-microsatellite-status-characterization-in-gastrointestinal-cancers-in-the-era-of-cancer-precision-therapy/368631.png","ImageObject",300,407,{"name":42,"@type":43},"Rizky","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role do MSI/dMMR biomarkers play in gastrointestinal cancer management?","Question",{"text":63,"@type":64},"MSI/dMMR assessment is used to guide diagnostic-therapeutic decisions and to stratify response to immune checkpoint inhibitors. Accurate evaluation and reliable reporting by pathologists are emphasized as crucial in clinical decision-making.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How are microsatellite instability (MSI) and microsatellite status (MS) classified?",{"text":68,"@type":64},"MSI reflects changes in the number of tandem repeats due to DNA slippage during replication. Microsatellite status can be classified into high (MSI-H) or low (MSI-L) levels based on the number of mutated loci.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the function of the mismatch repair (MMR) system in maintaining microsatellite stability?",{"text":72,"@type":64},"The MMR system corrects replication errors by triggering cell cycle arrest and/or programmed cell death pathways. When MMR is deficient (dMMR), genetic errors accumulate, particularly at microsatellite loci that are prone to replication errors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368631,1790646655,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","PATHOLOGICA 2025;117:204-219; DOI: 10.32074/1591-951X-1110  \nReceived: October 2, 2024  \nAccepted: October 3, 2024  \nCorrespondence  \nMatteo Fassan  \n[E-mail: matteo.fassan@unipd.it](E-mail: matteo.fassan@unipd.it)  \nHow to cite this article: Gasparello J, Piva VM, Angerilli V, et al. Lights and shadows of microsatellite status characterization in gastrointestinal cancers in the era of cancer precision therapy. Pathologica 2025;117:204- 219; [https://doi.org/10.32074/1591-951X-1](https://doi.org/10.32074/1591-951X-1)110  \n© Copyright by Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology  \n OPEN ACCESS  \nThis is an open access journal distributed in accordance with the CC-BY-NC-ND (Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International) license: the work can be used by mentioning the author and the license, but only for non-commercial purposes and only in the original version. For further information: [https://creativecommons](https://creativecommons). org/licenses/by-nc-nd/4.0/deed.en  \nReview  \nLights and shadows of microsatellite status characterization in gastrointestinal cancers in the era of cancer precision therapy  \nJessica Gasparello1 , Vittoria Matilde Piva2 , Valentina Angerilli1 , Carlotta Ceccon1 , Marianna Sabbadin1,3 , Claudio Luchini4 , Paola Parente5 , Luisa Toffolatti3 , Federica Grillo6,7 , Francesca Bergamo2 , Umberto Malapelle8 , Sara Lonardi2 , Matteo Fassan1,2  \n1 Department of Medicine (DIMED), University of Padua, Padua, Italy; 2 Department of Oncology Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy; 3 Surgical Pathology Unit, ULSS2 Marca Trevigiana, Treviso, Italy; 4 Department of Diagnostics and Public Health, Section of Pathology, University and Hospital Trust of Verona, Verona, Italy; 5 Unit of Pathology, Fondazione IRCCS Ospedale Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Foggia, Italy;  \n6 Pathology Unit, Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy; 7 Pathology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; 8 Department of Public Health, University of Naples Federico II, Napoli, Italy  \nSummary  \nThe introduction of immunotherapy has dramatically changed the paradigm of solid tumor treatment with the creation of novel therapeutic opportunities even for tumors that currently lack valid therapeutic options in the advanced or metastatic setting. Initially, the role of deficient mismatch repair status (dMMR)/microsatellite instability (MSI) as a predictive biomarker was confined to colorectal cancer. In 2017, MSI/dMMR became the first true agnostic biomarker to stratify patient response to immune checkpoint inhibitors. MSI/ dMMR evaluation is a crucial point in diagnostic-therapeutic decision-making for most gastrointestinal cancer patients and the pathologist must be responsible for the delivery of reliable reporting in this setting. The aim of this review is to summarize the current methods available in routine diagnostics for the evaluation of MSI/dMMR status, their limitations, and potential pitfalls that can be encountered. The authors also give an overview of the role of MSI/dMMR as a prognostic and predictive biomarker in gastrointestinal cancers, with a focus on non-colorectal malignancies.  \nKey words: microsatellite, microsatellite instability, mismatch repair, gastrointestinal cancer  \nIntroduction  \nMicrosatellites are tandem repeats of short DNA motifs, composed of up to 9 base pairs (bp) and repeated many times throughout the genome1. DNA repeated motifs include mononucleotide repeats, dinucleotides, and tetranucleotides, generally rich in adenine (A) or thymine (T)2. Microsatellites are widely distributed throughout the entire genome but are predominantly found in noncoding regions including introns, 5’ and 3’ untranslated regions (UTRs), and intergenic regions3,4","cbCaihUIK3PnFuuT","https://ap.wps.com/l/cbCaihUIK3PnFuuT","pdf",1877242,16,"English","# Summary\n# Introduction\n# Role of mismatch repair system in microsatellite stability","[{\"question\":\"What role do MSI/dMMR biomarkers play in gastrointestinal cancer management?\",\"answer\":\"MSI/dMMR assessment is used to guide diagnostic-therapeutic decisions and to stratify response to immune checkpoint inhibitors. Accurate evaluation and reliable reporting by pathologists are emphasized as crucial in clinical decision-making.\"},{\"question\":\"How are microsatellite instability (MSI) and microsatellite status (MS) classified?\",\"answer\":\"MSI reflects changes in the number of tandem repeats due to DNA slippage during replication. Microsatellite status can be classified into high (MSI-H) or low (MSI-L) levels based on the number of mutated loci.\"},{\"question\":\"What is the function of the mismatch repair (MMR) system in maintaining microsatellite stability?\",\"answer\":\"The MMR system corrects replication errors by triggering cell cycle arrest and/or programmed cell death pathways. When MMR is deficient (dMMR), genetic errors accumulate, particularly at microsatellite loci that are prone to replication errors.\"}]","Lights and shadows of microsatellite status characterization in gastrointestinal cancers in the era of cancer precision therapy | PDF",1790177788,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da8281e0c70f532eed909b779009169e.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ca71970d93899ba7fe70c92a51a5366.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/134263a48fb6e736e7a82d1f59542fad.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/414db553ad42c037a611e6dd26d23f5a.webp",980,1306]